Aquestive Therapeutics In... (AQST)
NASDAQ: AQST
· Real-Time Price · USD
4.12
0.11 (2.74%)
At close: Aug 14, 2025, 3:59 PM
4.17
1.34%
Pre-market: Aug 15, 2025, 09:16 AM EDT
Aquestive Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 44.13M | 54.23M | 57.56M | 58.9M | 58.36M | 51.5M | 50.58M | 48.06M | 46.52M | 46.54M | 47.68M | 48.08M | 49.9M | 51.98M | 50.83M | 46.9M | 41.88M | 48.21M |
Cost of Revenue | 12.61M | 17.14M | 17.87M | 18.03M | 18.39M | 20.48M | 20.83M | 21.46M | 21.28M | 19.91M | 19.39M | 17.45M | 17.22M | 16.45M | 14.99M | 14.41M | 12.99M | 12.06M |
Gross Profit | 21.52M | 37.09M | 39.69M | 40.87M | 39.97M | 31.02M | 29.75M | 26.6M | 25.24M | 26.64M | 28.29M | 30.63M | 32.68M | 35.53M | 35.84M | 32.49M | 28.89M | 36.14M |
Operating Income | -52.6M | -41.18M | -30.77M | -21.1M | -15.19M | -19.45M | -914K | -7.72M | -14.19M | -22.75M | -42.07M | -43.02M | -42.14M | -35.89M | -34.68M | -38.66M | -44.47M | -37.56M |
Interest Income | 2.43M | 3.82M | 3.44M | 2.87M | 3.4M | 2.14M | 16.32M | 16.22M | 14.71M | 14.62M | 102K | 172K | 167K | 508K | 508K | 377K | 385K | 30K |
Pretax Income | -65.06M | -54.25M | -44.15M | -35.09M | -25.76M | -28.52M | -7.63M | -11.97M | -22.33M | -33.12M | -54.41M | -71M | -73.02M | -69.09M | -70.54M | -61.96M | -63.96M | -53.92M |
Net Income | -65.04M | -54.24M | -44.14M | -35.19M | -25.72M | -28.77M | 3.37M | -6.67M | -17.17M | -31.22M | -67.23M | -78.03M | -80.04M | -72.57M | -70.54M | -61.96M | -63.96M | -53.92M |
Selling & General & Admin | 59.91M | 58.56M | 50.18M | 43.72M | 38.98M | 34.98M | 31.75M | 34.01M | 39.09M | 47.31M | 52.88M | 56.05M | 55.72M | 53.27M | 53.48M | 54.08M | 53.75M | 54.51M |
Research & Development | 19.65M | 19.71M | 20.28M | 18.25M | 16.18M | 15.49M | 13.1M | 14.49M | 14.53M | 16.25M | 17.48M | 17.6M | 19.1M | 18.16M | 17.05M | 17.07M | 19.61M | 19.19M |
Other Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 79.56M | 78.27M | 70.46M | 61.97M | 55.16M | 50.47M | 44.85M | 48.51M | 53.62M | 63.57M | 70.36M | 73.65M | 74.81M | 71.43M | 70.52M | 71.15M | 73.36M | 73.7M |
Interest Expense | 9.92M | 16.89M | 16.82M | 15.83M | 12.94M | 10.18M | 7.46M | 5.93M | 8.31M | 10.45M | 12.45M | 14.33M | 17.23M | 19.88M | 22.55M | 23.68M | 19.87M | 16.4M |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 969K | 969K | 969K |
Cost & Expenses | 96.73M | 95.41M | 88.33M | 80M | 73.55M | 70.96M | 65.69M | 69.96M | 74.9M | 83.48M | 89.75M | 91.1M | 92.04M | 87.87M | 85.51M | 85.56M | 86.34M | 85.76M |
Income Tax Expense | -14K | -14K | -14K | 101K | -39K | 245K | -10.99M | -5.3M | -5.15M | -1.9M | 12.82M | 7.03M | 7.02M | 3.48M | -2K | -2K | 7K | 25K |
Shares Outstanding (Basic) | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 55.63M | 54.39M | 53.42M | 45.28M | 41.31M | 40.39M | 39.22M | 37.07M | 35.56M |
Shares Outstanding (Diluted) | 99.33M | 95.5M | 91.2M | 91.08M | 90.91M | 73.61M | 68.53M | 64.68M | 57.35M | 73.79M | 54.39M | 53.42M | 45.46M | 41.47M | 40.39M | 39.22M | 37.07M | 35.56M |
EPS (Basic) | -0.7 | -0.59 | -0.52 | -0.45 | -0.35 | -0.42 | 0.10 | -0.11 | -0.31 | -0.65 | -1.4 | -1.79 | -1.93 | -1.82 | -1.83 | -1.71 | -1.83 | -1.57 |
EPS (Diluted) | -0.7 | -0.59 | -0.52 | -0.45 | -0.35 | -0.42 | 0.01 | -0.2 | -0.4 | -0.74 | -1.4 | -1.79 | -1.93 | -1.82 | -1.83 | -1.71 | -1.83 | -1.57 |
EBITDA | -46.98M | -33.96M | -26.62M | -18.23M | -11.68M | -17.13M | 1.18M | -4.77M | -12.41M | -20.69M | -39.58M | -53.95M | -52.93M | -46.27M | -45.03M | -34.94M | -40.84M | -34.22M |
EBIT | -38.81M | -37.36M | -27.33M | -19.26M | -12.82M | -18.35M | -163K | -6.04M | -14.02M | -22.67M | -41.96M | -56.67M | -55.79M | -49.21M | -47.99M | -38.28M | -44.08M | -37.53M |
Depreciation & Amortization | 3.19M | 3.4M | 718K | 1.04M | 1.14M | 1.22M | 1.34M | 1.27M | 1.61M | 1.99M | 2.39M | 2.72M | 2.86M | 2.94M | 2.96M | 3.34M | 3.25M | 3.31M |